Tackling bias in AI health datasets through the STANDING Together initiative

Shaswath Ganapathi, Jo Palmer, Joseph E. Alderman, Melanie Calvert, Cyrus Espinoza, Jacqui Gath, Marzyeh Ghassemi, Katherine Heller, Francis Mckay, Alan Karthikesalingam, Stephanie Kuku, Maxine Mackintosh, Sinduja Manohar, Bilal A. Mateen, Rubeta Matin, Melissa McCradden, Lauren Oakden-Rayner, Johan Ordish, Russell Pearson, Stephen R. PfohlNegar Rostamzadeh, Elizabeth Sapey, Neil Sebire, Viknesh Sounderajah, Charlotte Summers, Darren Treanor, Alastair K. Denniston, Xiaoxuan Liu*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)2232-2233
Number of pages2
JournalNature Medicine
Volume28
Issue number11
Early online date26 Sept 2022
DOIs
Publication statusPublished - Nov 2022

Bibliographical note

Funding Information:
K.H., A.K., N.R. and S.R.P. are employees of Google. S.K. is a consultant for Hardian Health. D.T. and F.M. are funded by National Pathology Imaging Co-operative (NPIC, Pproject no. 104687), which is supported by a £50 million investment from the Data to Early Diagnosis and Precision Medicine strand of the government’s Industrial Strategy Challenge Fund, managed and delivered by UK Research and Innovation (UKRI). X.L., A.K.D., J.E.A. and J.P. are funded by NIHR, the NHS Transformation Directorate and the Health Foundation (AI_HI200014). M.J.C. is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for the Centre for Patient Reported Outcomes Research and is a National Institute for Health and Care Research (NIHR) Senior Investigator. M.J.C. receives funding from the NIHR, UK Research and Innovation (UKRI), NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR ARC West Midlands, UK SPINE, European Regional Development Fund – Demand Hub and Health Data Research UK at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, Janssen, GSK and Gilead, has received personal fees from Astellas, Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work; a family member of M.J.C. owns shares in GSK. ES receives research funding from UKRI (MR/V033654/1 and MR/S002782/1), the British Lung Foundation, and Alpha 1 Foundation and NIHR. C.S. receives research funding from the National Institute for Health and Care Research (NIHR133788), UKRI (MR/P502091/1 and MR/X005070/1), the Wellcome Trust, and the NIHR Cambridge Biomedical Research Centre (BRC1215-20014). All other authors declare no conflicts.

This project is funded by The NHS AI Lab at the NHS Transformation Directorate and the Health Foundation and managed by the National Institute for Health and Care Research (AI_HI200014). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS Transformation Directorate, the Health Foundation or the National Institute for Health and Care Research.

ASJC Scopus subject areas

  • General Biochemistry,Genetics and Molecular Biology

Cite this